Editas Medicine (EDIT) Reports Q1 Loss of $0.60

Editas Medicine (NASDAQ: EDIT) reported Q1 EPS of ($0.60), versus $0.67 reported last year. Revenue for the quarter came in at $2.07 million, versus $3.93 million reported last year.

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• S&P 500 may pull back before midterms, but Citi says buy the dip